{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:07:26Z","timestamp":1770062846298,"version":"3.49.0"},"reference-count":42,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["716344"],"award-info":[{"award-number":["716344"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["431984000\u2013SFB"],"award-info":[{"award-number":["431984000\u2013SFB"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["390939984"],"award-info":[{"award-number":["390939984"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)","award":["716344"],"award-info":[{"award-number":["716344"]}]},{"name":"Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)","award":["431984000\u2013SFB"],"award-info":[{"award-number":["431984000\u2013SFB"]}]},{"name":"Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)","award":["390939984"],"award-info":[{"award-number":["390939984"]}]},{"name":"Germany\u2019s Excellence Strategy","award":["716344"],"award-info":[{"award-number":["716344"]}]},{"name":"Germany\u2019s Excellence Strategy","award":["431984000\u2013SFB"],"award-info":[{"award-number":["431984000\u2013SFB"]}]},{"name":"Germany\u2019s Excellence Strategy","award":["390939984"],"award-info":[{"award-number":["390939984"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Neuronal ceroid lipofuscinoses type 2 (CLN2), the most common form of Batten disease, is caused by TPP1 loss of function, resulting in tripeptidyl peptidase-1 enzyme deficiency and cerebral accumulation of lipopigments. Clinical hallmarks include epileptic seizures, vision loss, progressive movement disorder, ataxia, and eventually death. Diagnosis is often delayed due to the rarity of the conditions. Results: Here, we report a case presenting with clinical features of CLN2, carrying a homozygous novel nonsense variant in TPP1 (NM_000391:c.C832T, (p.Q278*), rs1352347549). Moreover, we performed a comprehensive literature review regarding previously identified disease-causing TPP1 mutations and genotype-phenotype correlations. Conclusion: Depending on the type of mutation, different phenotypes are observed in patients with CLN2, suggesting that the severity of phenotypes is related to the genotype of the patients.<\/jats:p>","DOI":"10.3390\/jcm11216415","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:26:50Z","timestamp":1667114810000},"page":"6415","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of a TPP1 Q278X Mutation in an Iranian Patient with Neuronal Ceroid Lipofuscinosis 2: Literature Review and Mutations Update"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5352-0171","authenticated-orcid":false,"given":"Tayebeh","family":"Baranzehi","sequence":"first","affiliation":[{"name":"Departement of Biology, University of Sistan and Baluchestan, Zahedan 9816745845, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-4785","authenticated-orcid":false,"given":"Dor Mohammad","family":"Kordi-Tamandani","sequence":"additional","affiliation":[{"name":"Departement of Biology, University of Sistan and Baluchestan, Zahedan 9816745845, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Najafi","sequence":"additional","affiliation":[{"name":"Pediatric Genetics Division, Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg University Faculty of Medicine, 79106 Freiburg, Germany"},{"name":"Genome Research Division, Human Genetics Department, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Khajeh","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan 9816745845, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1714-6749","authenticated-orcid":false,"given":"Miriam","family":"Schmidts","sequence":"additional","affiliation":[{"name":"Pediatric Genetics Division, Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg University Faculty of Medicine, 79106 Freiburg, Germany"},{"name":"Genome Research Division, Human Genetics Department, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands"},{"name":"CIBSS\u2014Center for Integrative Biological Signaling Studies, University of Freiburg, 79104 Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Angural, A., Ponnusamy, K., Langeh, D., Kumari, M., Spolia, A., Rai, E., and Sharma, S. (2021). Missense Variation in TPP1 Gene causes Neuronal Ceroid Lipofuscinosis Type 2 in a Family from Jammu and Kashmir-India. Preprints, 2021070661.","DOI":"10.20944\/preprints202107.0661.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.seizure.2018.08.027","article-title":"Homozygous missense TPP1 mutation associated with mild late infantile neuronal ceroid lipofuscinosis and the genotype-phenotype correlation","volume":"69","author":"Chen","year":"2018","journal-title":"Seizure"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.29271\/jcpsp.2020.05.543","article-title":"A Case with Neonatal-onset Type 2 Neuronal Ceroid Lipofuscinosis: A Novel Mutation","volume":"30","author":"Uygur","year":"2020","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","article-title":"The neuronal ceroid-lipofuscinoses: A historical introduction","volume":"1832","author":"Haltia","year":"2013","journal-title":"Biochim. Et Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"754045","DOI":"10.3389\/fneur.2021.754045","article-title":"The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses","volume":"12","author":"Gardner","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/humu.23860","article-title":"Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease","volume":"40","author":"Gardner","year":"2019","journal-title":"Hum. Mutat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10072-021-05067-8","article-title":"Neuronal ceroid lipofuscinosis: Genetic and phenotypic spectrum of 14 patients from Turkey","volume":"42","author":"Kose","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100718","DOI":"10.1016\/j.ymgmr.2021.100718","article-title":"Real world effectiveness of cerliponase alfa in classical and atypical patients. A case series","volume":"27","author":"Segura","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s004010000321","article-title":"Distribution and development of CLN2 protein, the late-infantile neuronal ceroid lipofuscinosis gene product","volume":"102","author":"Kurachi","year":"2001","journal-title":"Acta Neuropathol."},{"key":"ref_10","first-page":"40","article-title":"Enzyme based diagnosis of type 1 and 2 neuronal ceroid lipofuscinoses","volume":"1","author":"Radwan","year":"2021","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-8-19","article-title":"Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy","volume":"8","author":"Santorelli","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.gene.2012.12.058","article-title":"Neuronal ceroid lipofuscinosis type CLN2: A new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America","volume":"516","author":"Kohan","year":"2013","journal-title":"Gene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fgene.2019.00370","article-title":"Next-Generation Sequencing Analysis Reveals Novel Pathogenic Variants in Four Chinese Siblings with Late-Infantile Neuronal Ceroid Lipofuscinosis","volume":"10","author":"Ren","year":"2019","journal-title":"Front. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1002\/mgg3.1228","article-title":"Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers","volume":"8","author":"Kozina","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jmg.39.11.822","article-title":"Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles","volume":"39","author":"Ju","year":"2002","journal-title":"J. Med. Genet."},{"key":"ref_16","first-page":"489","article-title":"R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis","volume":"44","author":"Logan","year":"2003","journal-title":"Croat. Med. J."},{"key":"ref_17","unstructured":"Goetz, M., and Istrail, S. (2021). Alternative Splicing Analysis of Tripeptidyl Peptidase 1 Mutations in CLN2 Batten Disease Models, Brown University. Presented at the Data Science Initiative."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102323","DOI":"10.1016\/j.scr.2021.102323","article-title":"Generation of Pathogenic TPP1 Mutations in Human Stem Cells as a Model for CLN2 Disease","volume":"53","author":"Ma","year":"2021","journal-title":"Stem Cell Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1074\/jbc.M313173200","article-title":"N-Glycosylation Is Crucial for Folding, Trafficking, and Stability of Human Tripeptidyl-peptidase I","volume":"279","author":"Wujek","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1515\/BC.2006.135","article-title":"Tripeptidyl-peptidase I in health and disease","volume":"387","author":"Golabek","year":"2006","journal-title":"Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.nbd.2019.03.025","article-title":"Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2, 2)-dimethyl butyrate, a brain endogenous ligand of PPAR\u03b1: Implications for late-infantile Batten disease therapy","volume":"127","author":"Chakrabarti","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows\u2013Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/jpc.15250","article-title":"Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world","volume":"57","author":"Pessoa","year":"2021","journal-title":"J. Paediatr. Child Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/epi.13820","article-title":"Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease","volume":"58","author":"Specchio","year":"2017","journal-title":"Epilepsia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s10072-015-2272-4","article-title":"A novel CLN2\/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis","volume":"36","author":"Yu","year":"2015","journal-title":"Neurol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104259","DOI":"10.1016\/j.ejmg.2021.104259","article-title":"Aberrant splicing and transcriptional activity of TPP1 result in CLN2-like disorder","volume":"64","author":"Helman","year":"2021","journal-title":"Eur. J. Med. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.braindev.2019.05.001","article-title":"Perampanel attenuates myoclonus in a patient with neuronal ceroid lipofuscinoses type 2 disease","volume":"41","author":"Wong","year":"2019","journal-title":"Brain Dev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pediatrneurol.2016.02.015","article-title":"Chorea in Late-Infantile Neuronal Ceroid Lipofuscinosis: An Atypical Presentation","volume":"60","author":"Saini","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.braindev.2011.12.005","article-title":"Clinical study in Chinese patients with late-infantile form neuronal ceroid lipofuscinoses","volume":"34","author":"Chang","year":"2012","journal-title":"Brain Dev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymgme.2007.08.124","article-title":"CLN2\/TPP1 deficiency: The novel mutation IVS7-10A> G causes intron retention and is associated with a mild disease phenotype","volume":"93","author":"Bessa","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"\u0141ugowska, A., Purzycka-Olewiecka, J.K., P\u0142oski, R., Truszkowska, G., Pronicki, M., Felczak, P., and Bednarska-Makaruk, M. (2021). Tripeptidyl Peptidase 1 (TPP1) Deficiency in a 36-Year-Old Patient with Cerebellar-Extrapyramidal Syndrome and Dilated Cardiomyopathy. Life, 12.","DOI":"10.3390\/life12010003"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1145>3.0.CO;2-Z","article-title":"Two novel CLN2 gene mutations in a Chinese patient with classical late-infantile neuronal ceroid lipofuscinosis","volume":"99","author":"Lam","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13052-020-00860-1","article-title":"Targeted re-sequencing for early diagnosis of genetic causes of childhood epilepsy: The Italian experience from the \u2018beyond epilepsy\u2019 project","volume":"46","author":"Amadori","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/mgme.1999.2853","article-title":"Late Infantile Neuronal Ceroid Lipofuscinosis Is Due to Splicing Mutations in the CLN2 Gene","volume":"67","author":"Hartikainen","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gall, K., Izzo, E., Sepp\u00e4l\u00e4, E.H., Alakurtti, K., Koskinen, L., Saarinen, I., and Alastalo, T.P. (2021). Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0255933"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-008-0349-3","article-title":"Atypical CLN2 with later onset and prolonged course: A neuropathologic study showing different sensitivity of neuronal subpopulations to TPP1 deficiency","volume":"116","author":"Elleder","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pediatrneurol.2009.04.022","article-title":"Late Infantile Neuronal Ceroid Lipofuscinosis: A New Mutation in Arabs","volume":"41","author":"Halevi","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/jpc.14890","article-title":"Neuronal ceroid lipofuscinosis type 2: An Australian case series","volume":"56","author":"Johnson","year":"2020","journal-title":"J. Paediatr. Child Health"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/humu.22292","article-title":"Autosomal recessive spinocerebellar ataxia 7 (SCAR 7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN 2 disease)","volume":"34","author":"Sun","year":"2013","journal-title":"Hum. Mutat."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Sheth, J., Mistri, M., Bhavsar, R., Pancholi, D., Kamate, M., Gupta, N., Kabra, M., Mehta, S., Nampoothiri, S., and Thakker, A. (2018). Batten disease: Biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients. BMC Neurol., 18.","DOI":"10.1186\/s12883-018-1206-1"},{"key":"ref_42","first-page":"42","article-title":"Juvenile Neuronal Ceroid Lipofuscinosis in a Patient of Iranian Origin","volume":"6","author":"Karimi","year":"2018","journal-title":"Razavi Int. J. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/21\/6415\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:05:44Z","timestamp":1760144744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/21\/6415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":42,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["jcm11216415"],"URL":"https:\/\/doi.org\/10.3390\/jcm11216415","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]}}}